Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122735104 | 12273510 | 4 | F | 2014 | 20160907 | 20160415 | 20160913 | PER | US-PFIZER INC-2016181481 | PFIZER | 77.00 | YR | F | Y | 68.00000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122735104 | 12273510 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, DAILY | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | |||||||
| 122735104 | 12273510 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY (TAKEN IN AM) | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 122735104 | 12273510 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, DAILY | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | |||||||
| 122735104 | 12273510 | 4 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0.5 MG, 2X/DAY | U | 18276 | .5 | MG | BID | |||||||
| 122735104 | 12273510 | 5 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK, AS NEEDED (0.25 MG 1/2 TABLET B.I.D.) | U | 18276 | ||||||||||
| 122735104 | 12273510 | 6 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 3X/DAY | U | 20235 | 300 | MG | TID | |||||||
| 122735104 | 12273510 | 7 | SS | GABAPENTIN. | GABAPENTIN | 1 | 1X/DAY (AT BEDTIME) | U | 20235 | QD | |||||||||
| 122735104 | 12273510 | 8 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 12.5 MG, 2X/DAY (25 MG, 1/2 TWICE A DAY) | U | 0 | 12.5 | MG | BID | ||||||
| 122735104 | 12273510 | 9 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 10 MG, 1X/DAY (TAKEN AT BEDTIME) | U | 0 | 10 | MG | QD | |||||||
| 122735104 | 12273510 | 10 | C | ASPIRIN 81 | ASPIRIN | 1 | 1X/DAY (IN THE EVENING) | 0 | QD | ||||||||||
| 122735104 | 12273510 | 11 | C | Centrum silver multivitamin women 50+ | 2 | 1X/DAY (IN AM) | 0 | QD | |||||||||||
| 122735104 | 12273510 | 12 | C | Calcium citrate w/ vitamin D | 2 | 630 MG, 1X/DAY (IN AM) | 0 | 630 | MG | QD | |||||||||
| 122735104 | 12273510 | 13 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 15 MG, 1X/DAY (AT BEDTIME) | 0 | 15 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122735104 | 12273510 | 1 | Depression |
| 122735104 | 12273510 | 2 | Anxiety |
| 122735104 | 12273510 | 3 | Anxiety disorder |
| 122735104 | 12273510 | 4 | Anxiety |
| 122735104 | 12273510 | 6 | Pain in extremity |
| 122735104 | 12273510 | 8 | Blood pressure abnormal |
| 122735104 | 12273510 | 9 | Blood cholesterol |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122735104 | 12273510 | Defaecation urgency | |
| 122735104 | 12273510 | Diarrhoea | |
| 122735104 | 12273510 | Merycism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122735104 | 12273510 | 2 | 2008 | 0 | ||
| 122735104 | 12273510 | 3 | 201505 | 0 | ||
| 122735104 | 12273510 | 4 | 2015 | 0 | ||
| 122735104 | 12273510 | 6 | 2015 | 0 | ||
| 122735104 | 12273510 | 8 | 2000 | 0 | ||
| 122735104 | 12273510 | 9 | 2000 | 0 |